Resonance Specialities Reports Strong Financial Performance in Q2 FY25.

Oct 23 2024 05:46 PM IST
share
Share Via
Resonance Specialities, a microcap company in the chemicals industry, has reported a significant improvement in its financial performance for the quarter ending September 2024. The company's PBT and PAT have increased by 274.47% and 272.2% respectively, while net sales have grown by 78.11%. However, DPS and DPR have shown a decline in the last five years.

Resonance Specialities, a microcap company in the chemicals industry, has recently announced its financial results for the quarter ending September 2024. The company’s stock has been given a ‘Hold’ call by MarketsMOJO.

According to the financial report, Resonance Specialities has shown a very positive performance in the quarter, with a score of 25, a significant improvement from 0 in the last 3 months. This is a result of various factors that have contributed to the company’s growth.


One of the key highlights of the financial report is the growth in Profit Before Tax less Other Income (PBT) and Profit After Tax (PAT), which have increased by 274.47% and 272.2% respectively, compared to the same quarter last year. This indicates a very positive trend in the company’s near-term profitability.


The company’s net sales have also shown a significant increase, with the highest recorded at Rs 18.06 crore in the last five quarters. This is a growth of 78.11% compared to the same quarter last year, showcasing a very positive trend in the company’s sales performance.


Resonance Specialities has also shown improvement in its operating profit margin, with the highest recorded at 13.01% in the last five quarters. This indicates an increase in the company’s efficiency.


However, the company’s dividend per share (DPS) and dividend payout ratio (DPR) have shown a decline in the last five years. This means that the company is distributing lower dividends to its shareholders compared to previous years.


Overall, Resonance Specialities has shown a very positive financial performance in the quarter ending September 2024. With increasing profitability and a positive trend in key financial indicators, the company is on a path of growth and success.


{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is Resonance Speci. falling/rising?
Dec 11 2025 12:42 AM IST
share
Share Via
Is Resonance Speci. overvalued or undervalued?
Dec 05 2025 08:34 AM IST
share
Share Via
Is Resonance Speci. overvalued or undervalued?
Nov 20 2025 08:06 AM IST
share
Share Via
Is Resonance Speci. overvalued or undervalued?
Nov 19 2025 08:09 AM IST
share
Share Via
Is Resonance Speci. overvalued or undervalued?
Nov 18 2025 08:24 AM IST
share
Share Via